ICON, a provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has reported net revenue of $233.04m for the fiscal second quarter ended 30 June 2011, an increase of 4.2%, compared to $223.75m for the same period in 2010.
Subscribe to our email newsletter
For the second quarter of 2011, the company has generated net income of $13.08m, compared to $22.87m for the same period in 2010.
ICON’s income from operations was $15.51m, compared to $25.68m for the same period last year.
For the six months ended 30 June 2011, the company posted net revenue of $462.34m, compared to $442.86m for the same period in 2010.
Net income was $25.89m for the six months of 2011 compared to $45.07m in the prior year period.
The company’s income from operations was $31.48m, compared to $52.46m for the same period in 2010.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.